PS214. Agreement of Repeatability Coefficients for Within-Subject Carotid Artery Velocities with Snoring Application  by McCormick, Susan et al.
JOURNAL OF VASCULAR SURGERY
84S Abstracts June Supplement 2014to disclose; J. F. Hamming: Nothing to disclose; E. H.
Peters: Nothing to disclose; P. H. Quax: Nothing to
disclose; H. J. van Bockel: Nothing to disclose.
PS212.
Increased CircularRNA-16 in Acutely Symptomatic
Carotid Plaques: A Novel Mediator of Carotid Plaque
Rupture
Hernan A. Bazan1, Daniel Lightell2, W. Charles
Sternbergh1, T. Cooper Woods2. 1Surgery, Section of
Vascular/Endovascular Surgery, Ochsner Clinic, New
Orleans, La; 2Tulane Heart & Vascular Institute, New
Orleans, La
Objectives: Circular RNAs (circRNAs) are dynami-
cally expressed during development and possess binding
sites for microRNAs (miRs), small RNAs that negatively
regulate gene expression. We recently demonstrated that
miR-221, which is associated with vascular smooth muscle
cell (VSMC) proliferation and inhibition of apoptosis, is
decreased in acutely symptomatic carotid plaques. Because
circRNA-16 possesses binding sites for miR-221 through
seed sequences found within, we hypothesized that
circRNA-16 is increased in acutely symptomatic carotid
plaques.
Methods: Relative changes in gene expression levels
of circRNA-16 were compared using a real-time polymer-
ase chain reaction (PCR) assay and the DDCt method.
All samples were run in duplicate; mean and standard error
were calculated. One-way analysis of variance with the
Tukey test was used to determine signiﬁcance between
groups.
Results: Expression of circRNA-16 was conﬁrmed in
human VSMC using PCR and resistance to RNAse H.
To investigate its role in carotid plaque rupture, levels
of circRNA-16 were quantiﬁed in patients undergoing
urgent carotid endarterectomy for acute neurologic
symptoms (n ¼ 27), compared with asymptomatic ca-
rotid plaques (n ¼ 19). In contrast to miR-221,
circRNA-16 is increased in the urgent group comparedFig.with the asymptomatic carotid plaque group (1.51 6 0.26
vs 1.006 0.10, P ¼ .03; Fig).
Conclusions: We demonstrate circRNA-16 levels are
increased and miR-221 levels decreased in acutely
ruptured carotid plaques. Furthermore, our data suggest
that a circRNA-16/miR-221 axis may be important
in ﬁbrous cap degradation and rupture during the transi-
tion from a stable to an unstable carotid atherosclerotic
plaque.
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Application
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Besnike Ramadani, Edyta Ilczyk, Christopher Skelly.
Surgery, University of Chicago, Chicago, Ill
Objectives: To determine (1) within-subject variance
in carotid artery velocities as measured by ultrasound
(US) and (2) if snoring signiﬁcantly alters carotid velocities.
Methods: Eight individuals underwent 32 bilateral ca-
rotid artery US exams by two Registered Vascular Technol-
ogist (RVTs; four exams/subject, four subjects/RVT).
Steps were taken to ensure measurements were made at
identical sites under similar parameters for subsequent
exams. Peak systolic velocity (PSV) and end-diastolic veloc-
ity (EDV) were measured at eight locations. For each loca-
tion, limits of agreement was used to calculate PSV and
EDV repeatability coefﬁcients, which are the limits within
which 95% of the differences will lie for two measurements
made on the same subject. Repeatability coefﬁcients were
then used to determine signiﬁcance for observed velocity
changes in carotid arteries with and without stenosis during
mock snoring. They were also used to access velocity vari-
ability in patients scheduled for carotid endarterectomies
(CEAs). All US exams were performed in an Intersocietal
Accreditation Commission vascular testing accredited labo-
ratory by RVTs.
Results: Repeatability coefﬁcients for RVT A ranged
from 34 to 44 cm/s for PSV and 10 to 22 cm/s for
EDV. For RVT B they ranged from 30 to 65 and 8 to
19 cm/s for PSV and EDV, respectively. Maximum values
occurred at the ostia of the internal carotid artery (ICA)
and in the proximal ICA for RVTs A and B, respectively.
In nonstenosed arteries, snoring most frequently caused a
signiﬁcant change in the PSV of the proximal ICA and in
the EDV of the mid-ICA where it occurred 15% of the
time (three of 20 arteries). However, the effect of snoring
was greatest in stenosed arteries. In 38% (three of eight)
snoring caused a signiﬁcant increase in the PSV and EDV
of the proximal ICA and in the PSV of the mid-ICA.
Conclusions: Repeatability coefﬁcients can be used to
determine signiﬁcant changes in carotid artery velocities
within stenosis categories as measured by US. There is a
possible connection between snoring, carotid velocities,
and stenosis that warrants further investigation to deter-
mine if it is part of the mechanism by which snoring may
increase stroke risk.
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Zizimin1 Overexpression Impairs Vascular
Morphogenesis
Siavash Saadat, Yanmei Qi, Jie Liu, Alan Graham, Shaohua
Li. Rutgers-Robert Wood Johnson Medical School, New
Brunswick, NJ
Objectives: The Rho subfamily of small GTPases,
including RhoA, Rac1, and Cdc42, regulates diverse
cellular functions, including polarity, migration, and
actin-based cytoskeleton dynamics. Our prior studies estab-
lished an essential role for Cdc42 in vascular network as-
sembly, demonstrating that the genetic inactivation of
Cdc42 yields defective vascular morphogenesis due to
impaired migration of endothelial precursor cells. We
have further shown that protein kinase Ciota and glycogen
synthase kinase-3b are downstream effectors of Cdc42 and
are involved in mediating vascular network assembly. How-
ever, the guanine nucleotide exchange factors (GEFs) that
activate Cdc42, remain unknown.
Methods: We performed afﬁnity pulldown assays us-
ing a nucleotide-free Cdc42 G15A mutant that speciﬁcally
binds to Cdc42 GEFs. Mass spectrometric analysis identi-
ﬁed Zizimin1, an upstream regulatory protein, as a candi-
date Cdc42 GEF.
Results: During vasculogenesis in embryoid bodies
(EBs) differentiated from embryonic stem cells, Zizimin1
is highly expressed in aggregated endothelial cell precursors
before vascular network formation. Surprisingly, stable
overexpression of Zizimin1 in EBs resulted in the inhibi-
tion of blood vessel formation compared with control, evi-
denced by immunohistochemistry demonstrating loss of
vascular network development. Afﬁnity pulldown assay
helped to elucidate that overexpression of Zizimin1 in-
creases Cdc42 activity; however, the activation of Rac1
and RhoA is signiﬁcantly inhibited.
Conclusions: Because Rac1 and RhoA signaling has
been reported to play an essential role in embryonic blood
vessel formation, our results suggest that the interplay be-
tweenRhoGTPases guides vascular network assembly during
development. Furthermore, these ﬁndings provide novel in-
sights into the mechanisms of embryonic vasculogenesis
and also important new information for the design of poten-
tial proangiogenic and/or antiangiogenic therapies.
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Plasma and Patterning: The New Focus for the
Development of Nanocomposite Vascular Grafts
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Objectives: The concept of surface modulation holds
much promise for the future development of vascular
grafts. Our aim is to enhance a nanocomposite material us-
ing surface modiﬁcation techniques, such as plasma tech-
nology and surface patterning, to augment both surface
chemistry and topography with a view towards
endothelialization.
Methods: Polyhedral oligomeric silsesquioxane
(POSS) was combined with polycarbonate urea urethane
(PCU) to produce a nanocomposite polymer. Micro-
grooves with pitch size of 25 mm were created using
photolithography. Fidelity was veriﬁed with scanning elec-
tron microscopy (SEM) and atomic force microscopy
(AFM). The polymer was then exposed to pure O2 plasma
and contact angles were measured. Human umbilical vein
endothelial cells (HUVECs) were then seeded onto
POSS-PCU. The metabolic activity of the cells was
assessed, and immunostaining was used and subsequently
visualized with confocal microscopy.
Results: Contact angle results (mean, 85) show the
increased hydrophilicity of the polymer surface. Both
AFM and SEM conﬁrm the high replication ﬁdelity of
the microgrooves within the surface of the polymer using
photolithography. Metabolic activity of HUVECs on the
surface modiﬁed polymer was signiﬁcantly increased
compared with control (P < .05). Further immunostaining
conﬁrms the adhesive nature of the cells as well as the
migratory potential.
Conclusions: A combination of plasma technology
and surface patterning to augment both surface chemis-
try and topography on a nanocomposite polymer pro-
motes increased endothelial cell adhesion, migration,
and proliferation. The ordered microgrooves were seen
to enhance cellular adhesion and spreading. Plasma tech-
nology and microgrooving is a promising methodology
to optimize luminal endothelization and the prospect
for “self-endothelization.”
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Objectives: Despite prophylactic antibiotics and
aseptic technique, prosthetic graft infections continue to
cause signiﬁcant morbidity and mortality. In contemporary
reports, in vivo models have tested a conduit’s infectability
using concentrations from 104 to 109 colony-forming
units (CFU) per mL. Using an in vitro model, we evaluated
the impact of inoculation concentrations on prosthetic
graft attachment.
